We present a collection of Galaxy tools representing many popular algorithms for detecting somatic genetic alterations from cancer genome and exome data. We implemented methods for parallelization of these tools within Galaxy to accelerate runtime and have demonstrated their usability on cloud-based infrastructure and commodity hardware. Some tools represents extensions or refinement of existing toolkits to yield visualizations suited to cohort-wide cancer genomic analysis. For example, we present Oncocircos and Oncoprintplus, which generate data-rich summaries of exome-derived somatic mutation. Workflows that integrate several of these to perform some standard data integration and visualization tasks are demonstrated on a cohort of 96 diffuse large B-cell lymphomas, enabling the discovery of multiple candidate lymphoma-related genes that have not been reported previously.
Background
An inherent problem in the application of genomics to understand the molecular aetiology of cancer is the multi-disciplinary skillset required for researchers to draw meaningful inferences from high-throughput biological data. With the rise in popularity of high-throughput DNA sequencing, the bottleneck for novel discovery has shifted from data generation to data analysis and interpretation. Although myriad algorithms have been developed to efficiently analyze increasingly large datasets, these are often tailored for technically-inclined users. Specifically, they are typically run at the command line; their operation requires the use of cryptic parameters; and their installation is often burdensome. Data flow between tools is also often non-trivial and, owing to a paucity of data standards, can involve error-prone data manipulation and re-formatting steps. Combined with a necessity for high-performance computational hardware to run many such tools efficiently, this produces a tremendous barrier for new users.
There exists a handful of options that address this predicament in genomics as a whole.
Tools that automate pipeline development such as Kronos 1 , Nextflow 2 and Snakemake 3 can satisfy the needs of more technically savvy users. Alternatively, graphical user interfaces (GUIs)-which are generally lacking in the field of bioinformatics-aid in users learning the utility of the associated with command-line interfaces but typically do not scale to large data sets.
Examples of genomics tools offering web-accessible GUIs include BLAST 4 , VAGUE 5 and limmaGUI 6 . However, beyond an inability to scale, web-based utilities pose several issues, including design inconsistency, redundant efforts in interface development and the inability to automatically link individual tasks into pipelines or workflows. Ideally, any reduction in the barriers associated with running individual algorithms passing data between software tools should accelerate analytical tasks and reduce the risk of errors.
To overcome this, GUI-enabled software for automating pipeline development has been created to improve the reproducibility, accessibility and transparency of running genomic analyses 7 . Examples of these include Galaxy 8 , Taverna 9 , Pegasus 10 and commercial software packages such as Geneious 11 . In particular, the Galaxy project offers many attractive features for this goal while remaining open-source. Namely, Galaxy boasts extensive documentation; support for automatic tool installation; the ability to instantiate public or private "cloud clusters" by leveraging CloudMan 12 ; and is as a whole supported by a vibrant community that provides ongoing development to the software. Although algorithms for handling high-throughput sequence data are increasingly being added to Galaxy, there currently remains a general lack of tools and workflows specifically tailored to perform common tasks involved in analyzing cancer genome and exome sequence data. Here, we have begun to address this issue by adapting many of the popular tools for analyzing cancer genome and exome data for Galaxy and made these publicly available (https://github.com/morinlab/tools-morinlab). We demonstrate the utility of some of these by applying custom workflows to a large cohort of diffuse large B-cell lymphoma patients (n=96) and uncover new candidate lymphoma-related genes.
Results

Implementing cancer genomics tools in Galaxy
We produced a comprehensive toolkit comprising a suite of complementary tools and workflows that perform many of the routine analytical tasks in cancer genomics. These include several methods for detecting ("calling") somatic single nucleotide variants (SNVs), copy number variations (CNVs) and structural variations (SVs) in tumour-normal pairs. Additional tools were developed to perform the many auxiliary steps helper functions that allow these tools to be linked and applied generically, such as bam and text file pre-and post-processing, manipulating and converting file formats; variant annotation; identification of significantly mutated genes; and multiple visualization utilities for performing exploratory analysis and cohort-level data summarization. The tools and helper functions are detailed in Table 1 and Supplementary Table S1 , respectively. Details on the implementation of tools is included in the Methods section and can be further obtained from the latest versions hosted in our repository (https://github.com/morinlab/tools-morinlab).
There are numerous algorithms available to perform standard analytical tasks such as variant calling and CNV detection, each offering different balances of usability, computational efficiency and accuracy. As such, selection of ideal tools and parameters is non-trivial. We implemented tools representing some of the more commonly cited options and include many that performed favorably in ICGC-TCGA DREAM challenges 13 . As each tool can be configured with a number of parameters, which can be tuned for improved accuracy, we leverage results from the DREAM challenge to assist in selecting the more accurate algorithms and in setting sensible default parameters 14 . We have also released numerous workflows that run some of the more complicated pieces of software that relies on many dependencies and that perform some routine analytical and visualization tasks as detailed and illustrated with the real-world worked examples below. Example workflows that demonstrate our new approach to perform parallelization in Galaxy are also included ( Figure 1 ). As these migrate to the public Galaxy tool shed, we encourage ongoing testing and parameter optimization and community-driven refinement and expansion of this toolkit such that it may eventually constitute a hub for boilerplate cancer genome analyses.
Identifying novel candidate lymphoma-related genes from exome data An ultimate goal in cancer genome/exome analysis involves the identification of loci recurrently affected by copy number gain or loss and genes recurrently targeted by somatic mutations. There exist myriad tools to detect somatic SNVs and a growing number of options to derive high-quality copy number estimates from genome and, in less cases, exome data. We implemented workflows that perform the required annotation and pre-processing of raw mutation and copy number outputs from tools such as Strelka and Sequenza , respectively.
We ran these two workflows on 96 tumor/normal pairs representing diffuse large B-cell lymphoma (DLBCL) patients. The SNV and indel calls were annotated and converted into the standard mutation annotation format (MAF) using vcf2maf . We subsequently analyzed the pooled mutation calls from the meta-cohort for recurrently-mutated genes using oncodriveFM . Figure 3 shows the workflow that performs these tasks and produces various visualizations of the resulting gene set. Protein-centric lollipop plots, produced by a tool built on the maftools R package 15 , facilitate visual recognition of patterns indicative of tumor suppressor genes and can also reveal mutation clustering and, in the extreme example, hot spots (e.g. TMEM30A and NFKBIE ). Mutations in the latter two genes have previously been associated with DLBCL including a recurrent frameshift inducing indel observed here 16 , 17 . SPEN , in contrast, has not been reported as recurrent target of somatic mutation in DLBCL but has been found mutated in other lymphoma types. The pattern of mutations suggests it may also act as a tumor suppressor gene in this cancer. We further noted TET2 , SETD1B , ARID1A , UBR5 , DNMT3B and BTK demonstrate similar mutation patterns. Although these have been identified as relevant genes in other cancers 18 , 19 , none of these have, to our knowledge, been previously ascribed to DLBCL.
We next attempted to integrate the exome-derived copy number information with the mutation calls. Circos is a popular approach to generate visualizations of genome-wide mutation data although it is generally better suited for genome-wide data and the representation of structural alterations and CNVs relative to genomic coordinates 20 . For our application, we extended Circos to generate a gene-centric summarization of SNV and CNV data and produced the Oncocirc os Galaxy tool. Rather than plotting on a genomic coordinate scale, gene-level summaries of mutation data are mapped to their relative order on each chromosome and intergenic space (and genes with mutations below the threshold) are eliminated. To accomplish this, we implemented a custom parser that tabulates the data from MAF and segmented copy number files, applying a threshold to restrict the display to genes with a greater number of mutations cohort-wide.
Oncocircos also accepts user-provided gene lists and regions of recurrent CNV (e.g. from GISTIC ) and highlights these in the resulting image. Figure   4 shows the result of a workflow that runs GISTIC on a merged set of segmented data (in this example, from the Sequenza workflow) and integrates annotated SNV and indel calls from
Strelka . In this visualization, several known DLBCL-associated recurrent events are observed including amplifications affecting REL , MYC and BCL2 respectively on 2p, 8q and 18q.
Recurrent deletions affecting the loci containing known tumor suppressor genes are also observable. A complementary visualization of these data is a gene by patient oncostrip in which annotated copy number and point mutations can be represented ( Figure 6 and Supplemental Figure S4 ).
Discussion
Towards reproducible and distributable workflows for cancer genome analysis
Large-scale efforts to understand the diversity of cancer-associated somatic alterations across common cancer types are continually expanding in scope. Many such efforts release raw (or aligned) tumor and normal sequence data into controlled-access repositories such as dbGAP and the European Genome-Phenome Archive (EGA).
Owing to the many options and variations available in analytical methods, the mutations and copy number results presented along with these data are not directly amenable to direct comparisons between studies or pooled meta-analyses. Instead, the raw data must be obtained and processed uniformly alongside any new data sets. In light of the limited computational resources available to many research labs interested in incorporating existing sequence data into their analyses, some of the major data repositories are beginning to grant users permission to process patient data using cloud resources.
Availability and usability of analytical software are both critical factors in driving their adoption and the ultimate discovery of novel hallmarks. Accordingly, we provide a series of solutions that should accelerate adoption of our toolkit. First, providing automatic installation for tools wherever possible allow seamless integration into custom Galaxy instances. Second, many of the tools and workflows included here can be optionally configured to efficiently parallelize tasks on a cluster environment. Third, we show that our toolkit can be readily deployed onto a cloud-based Galaxy instance thereby eliminating the need for permanent access to commodity computing hardware.
Together, this offers the potential to enable reproducible cancer research by empowering researchers to perform their own cancer genome analyses with unprecedented accessibility and directly share their workflows such that analyses can be reproduced on additional datasets by other groups.
Herein, we have used our toolkit to demonstrate the potential for knowledge discovery and hypothesis generation in a large-scale analysis of exome data. By summarizing cohort-level mutations with multiple complementary visualization tools, we have detected potential mutation patterns and novel candidate lymphoma-related genes. Such approaches can enable the discovery of signatures associated with specific molecular subgroups such as the two known molecular subgroups in DLBCL, namely activated B-cell (ABC) and germinal centre B-cell (GCB) varieties. Of note, each of the oncoprintplus and oncostrip tools now allow a variety of metadata, for example molecular subgroup, to be overlaid and these can be used to order samples (e.g. Figure 5 ).
Enabling new insights into DLBCL biology
The combined workflows employed here leverage distinct aspects of mutational information that can be individually leveraged to identify candidate cancer drivers and further integrated to inform on disease biology. Using a combination of methods, we provide additional evidence for the importance of several that have been attributed to DLBCL with weak support to date and those whose role as an oncogene or tumor suppressor has not been elucidated. to be PMBCLs and the other was from the second cohort for which clinical data was unavailable. These observations may further support the presence of mutations that will facilitate detection of PMBCL cases that can be difficult to distinguish from DLBCL.
The integration of mutation with copy number data using our tools has further informed on the potential relevance of some candidate lymphoma-related genes.
TMEM30A demonstrated a mutation pattern indicative of tumor suppressor function ( Figure 3C ) and inspection of the oncocircos image suggest it resides within the commonly deleted region on 6q. Similarly, FAT1 appears to have a strong signature towards inactivation and resides in a substantially smaller region that is commonly lost.
Such patterns can be more readily confirmed using a separate visualization tool, namely oncostrip (Supplemental Figure S4) . In contrast, some of the significantly amplified regions of the genome do not appear to harbor genes with significant evidence for recurrent mutations. Amplifications that include JAK2 are known to be relevant to PMBCL but are not typically considered a feature of DLBCL. Upon inspection of the clinical data available for TCGA cases, we note that each of the four PMBCLs in this cohort contain a mutation or deletion affecting FAT1 and a JAK2 amplification.
POU2AF1 , which resides on 11q23.1, is a candidate target for the amplification of this region despite a low number of non-silent mutations and has been reported as commonly amplified in treatment-refractory DLBCLs 23 . Further studies that include larger cohorts and possibly whole genome sequence data should help confirm the relevance of these observations.
Many of the genes known to be relevant to DLBCL biology are more commonly mutated in only one of the two molecular subgroups. Figure 6 shows the mutation distribution across some of these genes in the meta-cohort analyzed here, which has been organized on the predicted subgroup of each patient. Using the oncostrip tool to order patients on this designation uncovers additional genes in which mutations may be more common in the GCB subgroup such as NFKBIE , ARID1A , FAS and STAT6 .
NFKBIE mutations have recently been reported to be particularly common among
PMBCLs and a marker of poor prognosis in that disease 24 . One of the NFKBIE mutations detected herein was in a PMBCL case whereas the remainder were in nodal DLBCL cases and was almost exclusively seen in cases with other mutations suggestive of the GCB subgroup. This indicates a potential unappreciated role of NFKBIE in DLBCL or, taken together with our observation of mutations in STAT6 and XPO1 , may suggest that a significant subset of PMBCL cases may masquerade as GCB DLBCL. Further refinement of the mutation patterns of the two subgroups of DLBCL and PMBCL using larger cohorts is clearly warranted.
Conclusions
Our toolkit provides a growing list of standard methods for cancer genomic analysis and facilitates their deployment in a simplified, reproducible and accessible manner using Galaxy. We have successfully run our tools and workflows using AWS cloud computing and CloudMan, which provides an cluster environment to any research lab.
We continue to provide new tools by extending functionality and updating versions as algorithms are refined. We also note that many of our tools have also been tested on whole genome sequence data and additional tools for performing analytical tasks better suited to that data type have been implemented but were not described in detail here.
To facilitate scaling of these applications to such applications and to accelerate the analysis of exomes, we established new methods to accomplish parallelization in Galaxy. Overall, the release of this suite of tools provides the methods essential to drive discovery and eliminate the bottleneck in cancer genomic analysis.
Methods
To integrate individual tools into Galaxy, we implemented XML-based configuration files which builds the command based on user-specified parameters. These contain a consistent design across tools and were developed using Planemo to ensure best practices 25 . All repositories are stored on the main public Galaxy toolshed, which allows users to automatically install any tool 26 . Modular tool dependency repositories provide the step-by-step instructions to compile necessary software for each tool.
Previously defined repositories were recycled if available. We could not successfully produce tools that automatically install on all platforms but many of the tools successfully install (with dependencies) on the standard Galaxy AWS image and in a custom Ubuntu installation (v16.04). Synthetic alignment data containing artificial variants were generated and bundled with variant callers to enable automatic testing 27 .
To handle reference data, we have developed new Galaxy data managers but also allow the option of user-provided reference data 28 .
We invested substantial effort to ensure that tools are parallelizable on cluster environments wherever it was deemed desirable and possible. Following the addition of new data types in the Galaxy codebase, this was subsequently re-implemented using the more transparent and efficient method that exploits the more recent Galaxy feature known as "data collections". Briefly, parallelization of a workflow is accomplished by a combination of tasks (Figure 1) , beginning with fetch_interval . This obtains chromosomal information from each input read alignment file and creates a collection of BED files defining all intervals available to each tool. To balance the load across all concurrently spawned jobs, we automatically pair large and small intervals. The second stage is a preprocess tool which defines all necessary preprocessing steps in a single tool and all will be executed together to reduce the numerous outputs associated with running multiple separate preprocessing tools in Galaxy. This includes a samtools flag and mapping quality filter, samtools remove duplicates and bamutils clipoverlap .
The third stage involves running the selected tool on each of the intervals, allowing Galaxy to spawn processes to available CPUs. The fourth stage is postprocess , which follows similar methodology to preprocess . Example usage includes further variant filtration and annotation steps. Finally all output files are merged, if necessary, so they may be supplied to subsequent tools and workflows. For tools that can be multithreaded, we instead leverage this capability instead of using chromosomal splitting.
Many of the analyses and workflows shown in detail in Figures 1-6 
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The TCGA exome data was obtained through dbGAP (phs000178.v9.p8 and phs000450.v2.p1) and the latter has been described previously 21 (A) Tools have been implemented to screen mutation data for patterns of recurrence and identify significantly mutated genes. Shown above is an example workflow that utilizes the OncodriveFM algorithm and generates various visualizations for genes meeting a pre-specified Q-value threshold. (B) A common approach to summarize mutation data is a two-dimensional matrix with covariates plotted along the side axes. We implemented a tool that leverages multiplot in our R package to generate such images for arbitrary gene lists using the outputs of variant calling workflows that have been annotated using the vcf2maf tool.
Mutations are colored based on the severity of mutations assigned automatically by the Ensembl Variant Effect Predictor (VEP) 47 . Genes with more severe mutations are more likely to be tumor suppressor genes (e.g. B2M at the bottom and TP53 and KMT2D at the top). Here, the total number of mutations detected in each patient is shown at the top and the P-value reported by Oncodrive FM is shown for each gene is shown on the right. The frequency of each of six possible mutation type can inform on mutational processes in individual samples. This is automatically determined from MAF files and is summarized at the top. (C) It is also often desirable to visualize the pattern of mutations within individual genes. The pattern is revealed using the lollypopplo t tool that is run on each gene passing the threshold in this workflow. With sufficiently large cohorts, the pattern of non-silent mutations within the protein can inform on genes under specific selective pressure. A clear pattern seen in many dominantly acting cancer genes are mutation hot spots. The OncodriveClust workflow searches for genes with significant clustering of mutations that may represent hot spots or regions/sites whose mutation may produce a dominant effect. Application of this workflow (A) detected many lymphoma-related genes known to harbor mutation clusters (B). The workflow automatically generates lollipop plots for all genes above a user-specified FDR (in this example, 0.3) (C).
Clear patterns of hot spots or mutation clusters are visible in each of these genes with only BRAF and MEF2C having been previously attributed to some DLBCLs 21 . DLBCL cases were assigned to either the ABC or GCB molecular subgroups using the presence of mutations known to be significantly restricted to either. Cases with no mutations unique to either molecular subgroup were designated unclassifiable (U). Figure S1 . Achieving parallelization in Galaxy.
There are two ways to achieve parallelization in Galaxy. The first (A) employs the parallelism tag, which calls specific split and merge functions depending on the galaxy input and output data type. These functions are predefined within galaxies codebase.
The second (B) uses galaxy collections, which are essentially containers of input files.
Inputs can be split into a collection of files and subsequently pipeline these through a series of tools. When complete, the individual outputs can be merged. Parallelizing using collections is far more transparent to the user and also limits that number of unnecessary split and merge functions.
Supplementary Figure S3 . A workflow to integrate SNV and CNV data and produce integrative visualizations.
This workflow uses exome-derived CNV and SNV data to generate a list of recurrently gained/lost genomic regions (using GISTIC ) and displays these along with gene-centric summaries of segmented copy number and SNV data using Oncocircos . To generate Figure 5 , we included a blacklist containing all immunoglobulin genes and Mucin genes whereas the genes identified as significantly mutated by oncodriveFM were provided separately to enforce highlighting.
Supplementary Figure S4 . Using the Oncostrip tool to integrate copy number and mutation data.
It can be desirable to visualize the complete set of mutational information cohort-wide without losing the patient-mutation relationships and potential gene-gene interactions that are not retained in Oncocircos . For this application, the oncostrip component of maftools can also accept raw outputs from GISTIC . Here, we have included the known gene targets of some recurrent amplifications and deletions detected in the cohort ( REL , B2M and TNFRSF14 ). Each of FAT1 and TMEM30A reside in significantly deleted regions and bear a combined pattern of mutation and deletion consistent with tumor suppressor function.
